世界の急性骨髄性白血病(AML)市場規模・現状・予測2021-2027

【英語タイトル】Global Acute Myeloid Leukemia Market Size, Status and Forecast 2021-2027

QYResearchが出版した調査資料(QY21APR0072)・商品コード:QY21APR0072
・発行会社(調査会社):QYResearch
・発行日:2021年4月(※2024年版があります。お問い合わせください)
・ページ数:91
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査資料では、急性骨髄性白血病(AML)の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(化学療法、放射線療法、幹細胞移植、標的療法、その他)、用途別市場規模(病院、小売ドラッグストア、外来診療センター、腫瘍学センター、クリニック)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・急性骨髄性白血病(AML)の市場動向
・企業の競争状況、市場シェア
・急性骨髄性白血病(AML)の種類別市場規模(化学療法、放射線療法、幹細胞移植、標的療法、その他)
・急性骨髄性白血病(AML)の用途別市場規模(病院、小売ドラッグストア、外来診療センター、腫瘍学センター、クリニック)
・急性骨髄性白血病(AML)の北米市場規模2016-2027(アメリカ、カナダ)
・急性骨髄性白血病(AML)の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・急性骨髄性白血病(AML)のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・急性骨髄性白血病(AML)の中南米市場規模2016-2027(メキシコ、ブラジル)
・急性骨髄性白血病(AML)の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Celgene Corporation、Cephalon、Clavis Pharma、Eisai、Genzyme Corporation、Sunesis Pharmaceuticals、Abbvie、Astellas Pharma、CTI Biopharma Corp)
・結論
【レポートの概要】

Leukemia are a heterogeneous group of cancers affecting the bone marrow and White Blood Cells (WBC). Leukemia is characterized by the rapid increase of abnormal blood cells growth or blasts, resulting in a decrease in the numbers of healthy, normal fully modified blood cells, leading to the typical symptoms of bleeding, anemia, and high risk of infection. 
Primary drivers boosting the growth of acute myeloid leukemia (AML) therapeutics market are minimal but increased prevalence of acute myeloid leukemia (AML), increased drug approval rate for AML, classification of acute myeloid leukemia (AML) as an orphan disease. Over the forecast period, population of people over 65 year is anticipated to increase, which is another key driver for acute myeloid leukemia (AML) therapeutics market.

Market Analysis and Insights: Global Acute Myeloid Leukemia Market
The global Acute Myeloid Leukemia market size is projected to reach US$ 2794.8 million by 2026, from US$ 1179.5 million in 2019, at a CAGR of 13.0% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Myeloid Leukemia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Myeloid Leukemia market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Myeloid Leukemia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Myeloid Leukemia market.

Global Acute Myeloid Leukemia Scope and Market Size
Acute Myeloid Leukemia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Myeloid Leukemia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Chemotherapy
Radiation Therapy
Stem Cell Transplant
Targeted Therapy
Others

Segment by Application
Hospital
Retails Drug Stores
Ambulatory Care Centers
Oncology Centers
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Celgene Corporation
Cephalon
Clavis Pharma
Eisai
Genzyme Corporation
Sunesis Pharmaceuticals
Abbvie
Astellas Pharma
CTI Biopharma Corp

【レポートの目次】

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Myeloid Leukemia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Chemotherapy
1.2.3 Radiation Therapy
1.2.4 Stem Cell Transplant
1.2.5 Targeted Therapy
1.2.6 Others
1.3 Market by Application
1.3.1 Global Acute Myeloid Leukemia Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Retails Drug Stores
1.3.4 Ambulatory Care Centers
1.3.5 Oncology Centers
1.3.6 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Acute Myeloid Leukemia Market Perspective (2016-2027)
2.2 Acute Myeloid Leukemia Growth Trends by Regions
2.2.1 Acute Myeloid Leukemia Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Myeloid Leukemia Historic Market Share by Regions (2016-2021)
2.2.3 Acute Myeloid Leukemia Forecasted Market Size by Regions (2022-2027)
2.3 Acute Myeloid Leukemia Industry Dynamic
2.3.1 Acute Myeloid Leukemia Market Trends
2.3.2 Acute Myeloid Leukemia Market Drivers
2.3.3 Acute Myeloid Leukemia Market Challenges
2.3.4 Acute Myeloid Leukemia Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Acute Myeloid Leukemia Players by Revenue
3.1.1 Global Top Acute Myeloid Leukemia Players by Revenue (2016-2021)
3.1.2 Global Acute Myeloid Leukemia Revenue Market Share by Players (2016-2021)
3.2 Global Acute Myeloid Leukemia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Myeloid Leukemia Revenue
3.4 Global Acute Myeloid Leukemia Market Concentration Ratio
3.4.1 Global Acute Myeloid Leukemia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Myeloid Leukemia Revenue in 2020
3.5 Acute Myeloid Leukemia Key Players Head office and Area Served
3.6 Key Players Acute Myeloid Leukemia Product Solution and Service
3.7 Date of Enter into Acute Myeloid Leukemia Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Acute Myeloid Leukemia Breakdown Data by Type
4.1 Global Acute Myeloid Leukemia Historic Market Size by Type (2016-2021)
4.2 Global Acute Myeloid Leukemia Forecasted Market Size by Type (2022-2027)

5 Acute Myeloid Leukemia Breakdown Data by Application
5.1 Global Acute Myeloid Leukemia Historic Market Size by Application (2016-2021)
5.2 Global Acute Myeloid Leukemia Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Acute Myeloid Leukemia Market Size (2016-2027)
6.2 North America Acute Myeloid Leukemia Market Size by Type
6.2.1 North America Acute Myeloid Leukemia Market Size by Type (2016-2021)
6.2.2 North America Acute Myeloid Leukemia Market Size by Type (2022-2027)
6.2.3 North America Acute Myeloid Leukemia Market Size by Type (2016-2027)
6.3 North America Acute Myeloid Leukemia Market Size by Application
6.3.1 North America Acute Myeloid Leukemia Market Size by Application (2016-2021)
6.3.2 North America Acute Myeloid Leukemia Market Size by Application (2022-2027)
6.3.3 North America Acute Myeloid Leukemia Market Size by Application (2016-2027)
6.4 North America Acute Myeloid Leukemia Market Size by Country
6.4.1 North America Acute Myeloid Leukemia Market Size by Country (2016-2021)
6.4.2 North America Acute Myeloid Leukemia Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Acute Myeloid Leukemia Market Size (2016-2027)
7.2 Europe Acute Myeloid Leukemia Market Size by Type
7.2.1 Europe Acute Myeloid Leukemia Market Size by Type (2016-2021)
7.2.2 Europe Acute Myeloid Leukemia Market Size by Type (2022-2027)
7.2.3 Europe Acute Myeloid Leukemia Market Size by Type (2016-2027)
7.3 Europe Acute Myeloid Leukemia Market Size by Application
7.3.1 Europe Acute Myeloid Leukemia Market Size by Application (2016-2021)
7.3.2 Europe Acute Myeloid Leukemia Market Size by Application (2022-2027)
7.3.3 Europe Acute Myeloid Leukemia Market Size by Application (2016-2027)
7.4 Europe Acute Myeloid Leukemia Market Size by Country
7.4.1 Europe Acute Myeloid Leukemia Market Size by Country (2016-2021)
7.4.2 Europe Acute Myeloid Leukemia Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Acute Myeloid Leukemia Market Size (2016-2027)
8.2 Asia-Pacific Acute Myeloid Leukemia Market Size by Type
8.2.1 Asia-Pacific Acute Myeloid Leukemia Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Myeloid Leukemia Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Myeloid Leukemia Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Myeloid Leukemia Market Size by Application
8.3.1 Asia-Pacific Acute Myeloid Leukemia Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Myeloid Leukemia Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Myeloid Leukemia Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Myeloid Leukemia Market Size by Region
8.4.1 Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Acute Myeloid Leukemia Market Size (2016-2027)
9.2 Latin America Acute Myeloid Leukemia Market Size by Type
9.2.1 Latin America Acute Myeloid Leukemia Market Size by Type (2016-2021)
9.2.2 Latin America Acute Myeloid Leukemia Market Size by Type (2022-2027)
9.2.3 Latin America Acute Myeloid Leukemia Market Size by Type (2016-2027)
9.3 Latin America Acute Myeloid Leukemia Market Size by Application
9.3.1 Latin America Acute Myeloid Leukemia Market Size by Application (2016-2021)
9.3.2 Latin America Acute Myeloid Leukemia Market Size by Application (2022-2027)
9.3.3 Latin America Acute Myeloid Leukemia Market Size by Application (2016-2027)
9.4 Latin America Acute Myeloid Leukemia Market Size by Country
9.4.1 Latin America Acute Myeloid Leukemia Market Size by Country (2016-2021)
9.4.2 Latin America Acute Myeloid Leukemia Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Acute Myeloid Leukemia Market Size (2016-2027)
10.2 Middle East & Africa Acute Myeloid Leukemia Market Size by Type
10.2.1 Middle East & Africa Acute Myeloid Leukemia Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Myeloid Leukemia Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Myeloid Leukemia Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Myeloid Leukemia Market Size by Application
10.3.1 Middle East & Africa Acute Myeloid Leukemia Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Myeloid Leukemia Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Myeloid Leukemia Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Myeloid Leukemia Market Size by Country
10.4.1 Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Celgene Corporation
11.1.1 Celgene Corporation Company Details
11.1.2 Celgene Corporation Business Overview
11.1.3 Celgene Corporation Acute Myeloid Leukemia Introduction
11.1.4 Celgene Corporation Revenue in Acute Myeloid Leukemia Business (2016-2021)
11.1.5 Celgene Corporation Recent Development
11.2 Cephalon
11.2.1 Cephalon Company Details
11.2.2 Cephalon Business Overview
11.2.3 Cephalon Acute Myeloid Leukemia Introduction
11.2.4 Cephalon Revenue in Acute Myeloid Leukemia Business (2016-2021)
11.2.5 Cephalon Recent Development
11.3 Clavis Pharma
11.3.1 Clavis Pharma Company Details
11.3.2 Clavis Pharma Business Overview
11.3.3 Clavis Pharma Acute Myeloid Leukemia Introduction
11.3.4 Clavis Pharma Revenue in Acute Myeloid Leukemia Business (2016-2021)
11.3.5 Clavis Pharma Recent Development
11.4 Eisai
11.4.1 Eisai Company Details
11.4.2 Eisai Business Overview
11.4.3 Eisai Acute Myeloid Leukemia Introduction
11.4.4 Eisai Revenue in Acute Myeloid Leukemia Business (2016-2021)
11.4.5 Eisai Recent Development
11.5 Genzyme Corporation
11.5.1 Genzyme Corporation Company Details
11.5.2 Genzyme Corporation Business Overview
11.5.3 Genzyme Corporation Acute Myeloid Leukemia Introduction
11.5.4 Genzyme Corporation Revenue in Acute Myeloid Leukemia Business (2016-2021)
11.5.5 Genzyme Corporation Recent Development
11.6 Sunesis Pharmaceuticals
11.6.1 Sunesis Pharmaceuticals Company Details
11.6.2 Sunesis Pharmaceuticals Business Overview
11.6.3 Sunesis Pharmaceuticals Acute Myeloid Leukemia Introduction
11.6.4 Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2016-2021)
11.6.5 Sunesis Pharmaceuticals Recent Development
11.7 Abbvie
11.7.1 Abbvie Company Details
11.7.2 Abbvie Business Overview
11.7.3 Abbvie Acute Myeloid Leukemia Introduction
11.7.4 Abbvie Revenue in Acute Myeloid Leukemia Business (2016-2021)
11.7.5 Abbvie Recent Development
11.8 Astellas Pharma
11.8.1 Astellas Pharma Company Details
11.8.2 Astellas Pharma Business Overview
11.8.3 Astellas Pharma Acute Myeloid Leukemia Introduction
11.8.4 Astellas Pharma Revenue in Acute Myeloid Leukemia Business (2016-2021)
11.8.5 Astellas Pharma Recent Development
11.9 CTI Biopharma Corp
11.9.1 CTI Biopharma Corp Company Details
11.9.2 CTI Biopharma Corp Business Overview
11.9.3 CTI Biopharma Corp Acute Myeloid Leukemia Introduction
11.9.4 CTI Biopharma Corp Revenue in Acute Myeloid Leukemia Business (2016-2021)
11.9.5 CTI Biopharma Corp Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Acute Myeloid Leukemia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Radiation Therapy
Table 4. Key Players of Stem Cell Transplant
Table 5. Key Players of Targeted Therapy
Table 6. Key Players of Others
Table 7. Global Acute Myeloid Leukemia Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Acute Myeloid Leukemia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Acute Myeloid Leukemia Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Acute Myeloid Leukemia Market Share by Regions (2016-2021)
Table 11. Global Acute Myeloid Leukemia Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Acute Myeloid Leukemia Market Share by Regions (2022-2027)
Table 13. Acute Myeloid Leukemia Market Trends
Table 14. Acute Myeloid Leukemia Market Drivers
Table 15. Acute Myeloid Leukemia Market Challenges
Table 16. Acute Myeloid Leukemia Market Restraints
Table 17. Global Acute Myeloid Leukemia Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Acute Myeloid Leukemia Market Share by Players (2016-2021)
Table 19. Global Top Acute Myeloid Leukemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia as of 2020)
Table 20. Ranking of Global Top Acute Myeloid Leukemia Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Acute Myeloid Leukemia Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Acute Myeloid Leukemia Product Solution and Service
Table 24. Date of Enter into Acute Myeloid Leukemia Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Acute Myeloid Leukemia Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Acute Myeloid Leukemia Revenue Market Share by Type (2016-2021)
Table 28. Global Acute Myeloid Leukemia Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Acute Myeloid Leukemia Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Acute Myeloid Leukemia Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Acute Myeloid Leukemia Revenue Market Share by Application (2016-2021)
Table 32. Global Acute Myeloid Leukemia Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Acute Myeloid Leukemia Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Acute Myeloid Leukemia Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Acute Myeloid Leukemia Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Acute Myeloid Leukemia Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Acute Myeloid Leukemia Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Acute Myeloid Leukemia Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Acute Myeloid Leukemia Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Acute Myeloid Leukemia Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Acute Myeloid Leukemia Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Acute Myeloid Leukemia Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Acute Myeloid Leukemia Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Acute Myeloid Leukemia Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Acute Myeloid Leukemia Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Acute Myeloid Leukemia Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Acute Myeloid Leukemia Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Acute Myeloid Leukemia Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Acute Myeloid Leukemia Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Acute Myeloid Leukemia Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Acute Myeloid Leukemia Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Acute Myeloid Leukemia Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Acute Myeloid Leukemia Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Acute Myeloid Leukemia Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Acute Myeloid Leukemia Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Acute Myeloid Leukemia Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Acute Myeloid Leukemia Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Acute Myeloid Leukemia Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Acute Myeloid Leukemia Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2022-2027) & (US$ Million)
Table 64. Celgene Corporation Company Details
Table 65. Celgene Corporation Business Overview
Table 66. Celgene Corporation Acute Myeloid Leukemia Product
Table 67. Celgene Corporation Revenue in Acute Myeloid Leukemia Business (2016-2021) & (US$ Million)
Table 68. Celgene Corporation Recent Development
Table 69. Cephalon Company Details
Table 70. Cephalon Business Overview
Table 71. Cephalon Acute Myeloid Leukemia Product
Table 72. Cephalon Revenue in Acute Myeloid Leukemia Business (2016-2021) & (US$ Million)
Table 73. Cephalon Recent Development
Table 74. Clavis Pharma Company Details
Table 75. Clavis Pharma Business Overview
Table 76. Clavis Pharma Acute Myeloid Leukemia Product
Table 77. Clavis Pharma Revenue in Acute Myeloid Leukemia Business (2016-2021) & (US$ Million)
Table 78. Clavis Pharma Recent Development
Table 79. Eisai Company Details
Table 80. Eisai Business Overview
Table 81. Eisai Acute Myeloid Leukemia Product
Table 82. Eisai Revenue in Acute Myeloid Leukemia Business (2016-2021) & (US$ Million)
Table 83. Eisai Recent Development
Table 84. Genzyme Corporation Company Details
Table 85. Genzyme Corporation Business Overview
Table 86. Genzyme Corporation Acute Myeloid Leukemia Product
Table 87. Genzyme Corporation Revenue in Acute Myeloid Leukemia Business (2016-2021) & (US$ Million)
Table 88. Genzyme Corporation Recent Development
Table 89. Sunesis Pharmaceuticals Company Details
Table 90. Sunesis Pharmaceuticals Business Overview
Table 91. Sunesis Pharmaceuticals Acute Myeloid Leukemia Product
Table 92. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2016-2021) & (US$ Million)
Table 93. Sunesis Pharmaceuticals Recent Development
Table 94. Abbvie Company Details
Table 95. Abbvie Business Overview
Table 96. Abbvie Acute Myeloid Leukemia Product
Table 97. Abbvie Revenue in Acute Myeloid Leukemia Business (2016-2021) & (US$ Million)
Table 98. Abbvie Recent Development
Table 99. Astellas Pharma Company Details
Table 100. Astellas Pharma Business Overview
Table 101. Astellas Pharma Revenue in Acute Myeloid Leukemia Business (2016-2021) & (US$ Million)
Table 102. Astellas Pharma Recent Development
Table 103. CTI Biopharma Corp Company Details
Table 104. CTI Biopharma Corp Business Overview
Table 105. CTI Biopharma Corp Acute Myeloid Leukemia Product
Table 106. CTI Biopharma Corp Revenue in Acute Myeloid Leukemia Business (2016-2021) & (US$ Million)
Table 107. CTI Biopharma Corp Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Myeloid Leukemia Market Share by Type: 2020 VS 2027
Figure 2. Chemotherapy Features
Figure 3. Radiation Therapy Features
Figure 4. Stem Cell Transplant Features
Figure 5. Targeted Therapy Features
Figure 6. Others Features
Figure 7. Global Acute Myeloid Leukemia Market Share by Application: 2020 VS 2027
Figure 8. Hospital Case Studies
Figure 9. Retails Drug Stores Case Studies
Figure 10. Ambulatory Care Centers Case Studies
Figure 11. Oncology Centers Case Studies
Figure 12. Clinics Case Studies
Figure 13. Acute Myeloid Leukemia Report Years Considered
Figure 14. Global Acute Myeloid Leukemia Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Acute Myeloid Leukemia Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Acute Myeloid Leukemia Market Share by Regions: 2020 VS 2027
Figure 17. Global Acute Myeloid Leukemia Market Share by Regions (2022-2027)
Figure 18. Global Acute Myeloid Leukemia Market Share by Players in 2020
Figure 19. Global Top Acute Myeloid Leukemia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Myeloid Leukemia as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Revenue in 2020
Figure 21. Global Acute Myeloid Leukemia Revenue Market Share by Type (2016-2021)
Figure 22. Global Acute Myeloid Leukemia Revenue Market Share by Type (2022-2027)
Figure 23. North America Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Acute Myeloid Leukemia Market Share by Type (2016-2027)
Figure 25. North America Acute Myeloid Leukemia Market Share by Application (2016-2027)
Figure 26. North America Acute Myeloid Leukemia Market Share by Country (2016-2027)
Figure 27. United States Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Acute Myeloid Leukemia Market Share by Type (2016-2027)
Figure 31. Europe Acute Myeloid Leukemia Market Share by Application (2016-2027)
Figure 32. Europe Acute Myeloid Leukemia Market Share by Country (2016-2027)
Figure 33. Germany Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Acute Myeloid Leukemia Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Acute Myeloid Leukemia Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Acute Myeloid Leukemia Market Share by Region (2016-2027)
Figure 43. China Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Acute Myeloid Leukemia Market Share by Type (2016-2027)
Figure 51. Latin America Acute Myeloid Leukemia Market Share by Application (2016-2027)
Figure 52. Latin America Acute Myeloid Leukemia Market Share by Country (2016-2027)
Figure 53. Mexico Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Acute Myeloid Leukemia Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Acute Myeloid Leukemia Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Acute Myeloid Leukemia Market Share by Country (2016-2027)
Figure 59. Turkey Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Acute Myeloid Leukemia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Celgene Corporation Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Figure 63. Cephalon Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Figure 64. Clavis Pharma Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Figure 65. Eisai Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Figure 66. Genzyme Corporation Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Figure 67. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Figure 68. Abbvie Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Figure 69. Astellas Pharma Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Figure 70. CTI Biopharma Corp Revenue Growth Rate in Acute Myeloid Leukemia Business (2016-2021)
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed


【掲載企業】

Celgene Corporation、Cephalon、Clavis Pharma、Eisai、Genzyme Corporation、Sunesis Pharmaceuticals、Abbvie、Astellas Pharma、CTI Biopharma Corp

★調査レポート[世界の急性骨髄性白血病(AML)市場規模・現状・予測2021-2027] (コード:QY21APR0072)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の急性骨髄性白血病(AML)市場規模・現状・予測2021-2027]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆